With the overuse of antibodies running rampant across the world, the threat of drug-resistant bacteria grows day-by-day. With our first-line antibiotics quickly becoming ineffective, we are forced more and more to use our “last resort” antibiotics. Vancomycin is one such antibiotic. While very effective against certain strains of bacteria, it can potentially have harmful side-effects if the dosage is not carefully controlled.

This is where we come in! We aim to design a cheap, yet reliable biosensor which will enable patients to easily track the amount of Vancomycin in their body. With that, we hope this form of convenient monitoring will help patients decide the correct dosage when it is needed.


We would like to thank all our sponsors. Without them our work would not be possible to continue.


We are the team representing Uppsala University in the SensUs Competition, which will be held in Eindhoven, Netherlands. SensUs is a yearly international student competition on molecular biosensors for healthcare applications. This year 13 university teams from different countries will compete with the focus on the Therapeutic Drug Monitoring (TDM) of Vancomycin. Read more about the competition here: http://sensus.org/




Email: uppsala.sensus@gmail.com
Phone: +46 73 975 1520